09:01:38 EDT Mon 20 May 2024
Enter Symbol
or Name
USA
CA



Navco Pharmaceuticals Inc
Symbol NAV
Shares Issued 57,069,541
Close 2024-04-12 C$ 0.025
Market Cap C$ 1,426,739
Recent Sedar Documents

Navco hires SOF Marketing for $300,000

2024-04-12 18:15 ET - News Release

Subject: Navco News For Dissemination Word Document

File: '\\swfile\EmailIn\20240412 150407 Attachment Navco - News Release Announcing Marketing Campaign -Final.docx'

LEGAL_43081416.1

LEGAL_43081416.1

Navco Announces Marketing Campaign

Vancouver, British Columbia--(April 12, 2024) - Navco Pharmaceuticals Inc. (TSXV: NAV) ("Navco" or the "Company"), announces that it has entered a contract with SOF Marketing for $300,000 CAD to broaden the company's reach within the investment community, to increase investor awareness of the company, and to attract potential new investors through various on-line platforms and methods of engagement. The marketing services include project management, rebranding, social media marketing, consulting for an on-line marketing campaign, co-ordinating marketing actions, maintaining and optimizing AdWords campaigns, adapting AdWords bidding strategies, optimizing AdWords ads, and creating and optimizing landing pages. The promotional activity will include e-mail, Facebook and Google and will last till October 12, 2024.

About the Company

Navco is a Burlington, Ontario - based company that is building a leading market position in the use of nanotechnology to develop and commercialize novel products against bacteria, viruses, fungi and infectious diseases. Navco has a portfolio of patent pending and Health Canada approved products. The Company's pipeline of applications is tailored to uniquely defend against pathogens utilizing new methods-of-action to capitalize on unmet health and product needs using natural & known compounds and nanoparticles with a high degree of efficacy. Target markets include human health & personal skin care, household & institutional products and veterinary health.

For additional information, please refer to the Company's disclosure record on SEDAR+ (www.sedarplus.ca) or contact the Company as follows: Geoffrey Lee, CEO, at 604-861-8980.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain statements contained in this press release constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", "will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions as they relate to the Company are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to it, and are subject to certain risks, uncertainties and assumptions. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize.

© 2024 Canjex Publishing Ltd. All rights reserved.